Clinical Trials Directory

Trials / Terminated

TerminatedNCT02499523

Monocentric Study on Acetabulum Patient-specific Pin Drilling Guides

Prospective Randomised Controlled Monocentric Study on Acetabulum Patient-specific Pin Drilling Guides

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Materialise · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, interventional, monocentric, controlled and randomized study will compare a conventional surgical technique to a surgical technique with the assistance of the Acetabular Cup Orientation Guide (ACOG, Materialise) System during total hip replacement (THR).

Detailed description

Background: The Acetabular Cup Orientation Guide(ACOG) System from MATERIALISE NV was developed and is intended to be used as a surgical instrument to assist in the positioning of acetabular cup components intra-operatively using anatomical landmarks of the pelvis that are clearly identifiable on preoperative computed tomography (CT) imaging scans. Use of ACOG is a relative new technique. ACOG, based on CT imaging data, fit directly into the patient's anatomy and enable primary total hip replacement . Data showing extra benefit of this technique compared to conventional THR technique are not widely available. Aim: To determine the safety of this new surgical technique compared to conventional THR. Methods: 30 participants will be randomized to 2 groups. One group will be operated for a THR with the conventional technique and the other group will be operated for a THR with the assistance of the ACOG System. CT imaging will be taken pre and post operatively to measure cup orientation.

Conditions

Interventions

TypeNameDescription
PROCEDURETHR with conventional techniqueTHR with conventional technique.
PROCEDURETHR with Acetabular Cup Orientation Guides (ACOG)THR with the ACOG System.

Timeline

Start date
2014-06-16
Primary completion
2016-10-21
Completion
2016-10-21
First posted
2015-07-16
Last updated
2017-03-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02499523. Inclusion in this directory is not an endorsement.